Wed, Jul 23, 2014, 4:25 AM EDT - U.S. Markets open in 5 hrs 5 mins


% | $
Click the to save as a favorite.

Prana Biotechnology Limited Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • gswkool gswkool Jan 2, 2012 12:06 PM Flag

    Next Milestone

    unfortunately the company market cap is too low, stock price is too low. The company may go broke before it is able to convince investors & possible partners that it has something of value to offer. Seen this before - companies on the cusp of a new discovery going bankrupt, only to have their patents/technologies acquired for pennies on the dollar. What's to prevent that from happening here ?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The trial is already ongoing. It is really too late to cut off their finance. The have a shelf selling at drip feed. Everything is going along nicely. They are getting some support from the Australian govt. They are getting support from the Vicorian state government in the form of the poweful research engine of the Mental Health Research Institute(MHRI). They can run on very low overheads if neeed.
      Bankrupt, no I dont think in this lifetime. The imaging trial cost is only $10m. The Huntingtons trial they are about to start, I hope, must be very basic with 100 patients over 6 months, at a cost of $2m in Aus and USA. I think they are getting some operational support from the HDSA.
      This Alzheimer's imaging trial that is currently running will very likely stop or reverse Alzheimer's. They have done it before, but this time there will be a full set of biomarker evidence from the various, PET scans, MRI's, blood tests to go with the cognition testing, a bigger sample, and more expertise on what to look for in the images. It will be very hard to ignore any results they see.
      My tip is the CSIRO(Aust Govt) picks it up and runs a pivitol trial for approval with their 900 paients they have on the AIBL study, with no pharma's involved.
      FYI, CSIRO is about the biggest research organization in the world. They have come up with things from the nuclear spectrometer, WiFi to an automatic sheep shearing machine. Currently working on making lower grades of iron ore commercial. They recently won a patent case on WiFi so I guess are cashed up. They have been working on the longitudinal AIBL study since 2004 with Prana's co founder Ashley Bush as co director. I think most of the funding came from the Govt of Western Australia for the AIBL. Prof Martins from UWA(Where Masters did his pioneering Alzheimer's work)is in charge of the study.
      The director of the MHRI is Prana co founder and Alzheimers research pioneer Colin Masters.
      AIBL are waiting for a genuine disease modifying drug to apply their discoveries from the AIBL study and I think, Prana, through this trial, will give it to them.
      I dont imagine Prana's connections in there will help and they will need to have the best prospect, but hey, they have already reversed Alzheimer's. Not too many can say that. Everything about the AIBL using PBT2 is just conjecture and I have seen nothing to indicate that may be the case.

    • You make a good point, gsw. I've occasionally pointed out that one possible future for Prana (of the company's many possible futures) is liquidation, where the company runs out of money and is unable to raise more, and ends up shutting down the business and selling the patents and other intellectual property for a pittance.

      I get excoriated whenever I mention that this is a possibility. But anyone who doesn't keep his eyes open to all possible outcomes shouldn't be speculating in early-stage biotech companies (or any other kind of company, for that matter).

      Prana clearly does not have enough cash to complete the HD and AD Phase IIa trials that are currently planned. I don't know where the money will come from, but I haven't been particularly impressed with Mr. Kempler's showmanship. Good showmanship is essential for a company like this, in order to keep the share price pumped up enough to make it possible to raise the necessary amount of cash.

      Kadaicher used to insist that a Big Pharma partnership was imminent. He may still be saying that, for all I know. But if a Big Pharma company were interested in a partnership, we would have had a partnership by now. I think that Big Pharma is waiting for the outcome of either or both of the Phase IIa trials.

      • 1 Reply to goutah3006
      • "I dont know where the money will come from". You dont know a lot Goutah.
        Let me explain it like I would to a small child. Maybe then you will understand.
        Prana hava a broker in the USA who has been instructed to sell stock on the open market. He is not to sell enough to cap the price, and he can only sell on an up tick. They announce it when it is used. Hasnt been used for a while, but they have sold 21% already according to a poster(Russ-Cindy)a few days back, so their drip feed method seems to be working well.
        Now as you know, a shelf filing in the USA is good for 2 years, but in Australia, it has to be re approved by stockholders every 3 months, so as this meeting nears it is a wonderful opportunity for bashers such as yourseld to cry, out of time and still not sold. Kind of strange you dont know where the money is to be sourced when you have already been crying about the three month renewals(deadlines). Something just not quite right there.

2.40-0.01(-0.41%)Jul 22 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.